Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| Sanofi | Sanofi opened a new position worth $37,268,786. | 2026-06-30 |
| SR One Capital Management, LP | SR One Capital Management, LP opened a new position worth $71,002,261. | 2026-06-30 |
| FMR LLC | FMR LLC opened a new position worth $51,793,284. | 2026-06-30 |
| ORBIMED ADVISORS LLC | ORBIMED ADVISORS LLC opened a new position worth $56,152,415. | 2026-06-30 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | LIGHTSPEED MANAGEMENT COMPANY, L.L.C. opened a new position worth $67,513,969. | 2026-06-30 |
| TPG GP A, LLC | TPG GP A, LLC opened a new position worth $69,042,632. | 2026-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | DEERFIELD MANAGEMENT COMPANY, L.P. opened a new position worth $19,573,261. | 2026-06-30 |
| Sands Capital Alternatives, LLC | Sands Capital Alternatives, LLC opened a new position worth $16,371,250. | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| SR One Capital Management, LP | $71,002,261 | 3,794,883 |
| TPG GP A, LLC | $69,042,632 | 3,690,146 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | $67,513,969 | 3,608,443 |
| ORBIMED ADVISORS LLC | $56,152,415 | 3,001,198 |
| FMR LLC | $51,793,284 | 2,768,214 |
| Sanofi | $37,268,786 | 1,991,918 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $19,573,261 | 1,046,139 |
| Sands Capital Alternatives, LLC | $16,371,250 | 875,000 |
| HHLR ADVISORS, LTD. | $15,560,284 | 831,656 |
| General Catalyst Group Management, LLC | $15,160,189 | 810,272 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
SR One Capital Management, LP is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This page tracks those disclosures over time, similar to how investors follow the largest hedge funds buying and selling names like UNH or watch a portfolio including cash evolve position by position. Each … Read more
This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more